方盛制药：张庆华质押的公司股份总数约为5533万股

Group 1 - The core point of the news is the shareholding structure and financial performance of Fangsheng Pharmaceutical, highlighting significant share pledges by major shareholders [1] - Zhang Qinghua directly holds approximately 156 million shares, accounting for 35.53% of the total shares [1] - The total number of shares pledged by Zhang Qinghua is about 55.33 million, representing 35.46% of his holdings and 12.6% of the total shares [1] - The company’s revenue composition for the first half of 2025 shows that pharmaceutical manufacturing accounts for 93.36% of total revenue [1] - As of the report, Fangsheng Pharmaceutical has a market capitalization of 5.4 billion yuan [1] Group 2 - The news mentions a significant development regarding the ownership and restructuring of Shanshan Group, indicating a complex situation involving private shipping tycoons [2]